Global Contract Pharmaceutical Dose Manufacturing Industry Report 2021 – ResearchAndMarkets.com |

0

DUBLIN – (BUSINESS WIRE) – October 20, 2021–

The “Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2021 Edition” report was added to ResearchAndMarkets.comoffer.

This expert trending report is a comprehensive overview of the 2021 finished dose contract manufacturing landscape, including an analysis of CMO’s merger and acquisition activity, size and share of Marlet. It is a critical source for strategic planning efforts and will improve understanding of critical supply chain components, which will provide information for supplier selection and management.

This expert trending report is a comprehensive overview of the 2021 Finished Commercial Dose Contract manufacturing landscape, including analysis of Dose CMO merger and acquisition activity, size and Part of the market. It is a critical source for strategic planning efforts and will improve understanding of critical supply chain components, which will provide information for supplier selection and management.

This report provides significant quantitative analysis from experts on the Commercial Contract Dose Manufacturing industry. Results are based on the industry’s most comprehensive CMO dose database (Contract Service Providers Database). The 8 tables and 21 figures throughout the report illustrate the main points and trends.

Scope

  • CMO Leaders and Strategic Decision Makers: Enhances understanding of the dose CMO industry and is a critical contribution to strategic planning efforts.
  • Procurement and purchasing managers in bio / pharmaceutical companies: improve understanding of critical components of the supply base that will provide information for the selection and management of suppliers.
  • Private Equity Investors: They can better understand the CMO market and important information to identify potential investment targets.

Reasons to buy

  • What is the geographic scope of Commercial Dose CMOs?
  • What is the 2020 revenue generated by the commercial contract dose manufacturing industry?
  • What are the components of the change in revenue for contract dose manufacturers?
  • What is the breakdown of 2020 sales by different dosage forms?
  • What are the characteristics of higher dose CMOs?
  • How does Contract Dose manufacturer revenue growth in 2020 compare to that of Contract API manufacturers?
  • What is the outlook for the CMO dose industry?
  • Which Dose CMO mergers and acquisitions took place in 2020?

Main topics covered:

  • Abstract
  • Players
  • Tendencies
  • Industry Analysis
  • Industry size and structure
  • Industry demographics
  • Major developments affecting the structure of the industry
  • Industry size and growth
  • Manufacturing of doses
  • CMO market shares
  • Characteristics of the largest CMOs
  • CMO and Payment Protection Program Loans
  • Analysis of Recent CMO Dose Industry Performance
  • The impact of COVID-19
  • Public CMO sales analysis
  • Changing Nature of Innovative FDA Approvals
  • What this means
  • Value chain
  • Companies

For more information on this report, visit https://www.researchandmarkets.com/r/42yod3

View source version on businesswire.com:https://www.businesswire.com/news/home/20211020005433/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Director

[email protected]

For EST office hours, call 1-917-300-0470

For USA / CAN call toll free 1-800-526-8630

For GMT office hours, call + 353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH

SOURCE: Research and markets

Copyright Business Wire 2021.

PUB: 10/20/2021 04:48 / DISC: 10/20/2021 04:48

http://www.businesswire.com/news/home/20211020005433/en

Copyright Business Wire 2021.


Source link

Share.

About Author

Comments are closed.